Chaparral (Larrea tridentata) leaf powder -Bulk.

CONTRAINDICATIONS:

In 1992, two people using large doses of chaparral in capsule form developed nonviral hepatitis and three others developed other symptoms of liver toxicity. This led the American Herbal Products Association and the U.S. Food and Drug Administration to issue a press release warning of potential risk from use of chaparral and suggesting that sale of chaparral be suspended. After more research, there was found to be no basis for the warning, and sale of chaparral was reinstated in 1995. There are still some precautions to take, nevertheless. Avoid chaparral during pregnancy and also while nursing. Excess use may be detrimental to the liver, kidneys, and lymphs. Discontinue use in case of fever, nausea, or jaundice (such as when the whites of the eyes become yellow).

These statements have not been evaluated by the Food and Drug Administration. Our products are not intended to diagnose, treat, cure, or prevent any disease.